IQVIA艾昆纬：药物开发中的人工智能-引导新兴的监管期望并加强临床试验报告（英文版）

Discover IQVIA's insights on integrating Artificial Intelligence (AI) and Machine Learning (ML) in drug development. This white paper, authored by Patrick Brady, PharmD, delves into the regulatory expectations and strategic implementation of AI/ML in clinical trials. It highlights the benefits of AI/ML across the drug development lifecycle, from patient recruitment to dose optimization, while emphasizing the importance of regulatory compliance and risk management. Learn about the latest r